Edwards Lifesciences to Acquire JenaValve and Endotronix in deals totaling $1.6B

Irvine, CA, July 25, 2024 (yahoo finance) -- Edwards Lifesciences is set to acquire JenaValve and Endotronix for $1.2 billion up front and additional $445 in milestone payments to expand its structural heart offerings. The acquisitions target new therapeutic areas such as aortic regurgitation and heart failure, aiming to drive long-term growth. These strategic moves come on the heels of Edward's buying Innovalve Bio Medical and taking a stake in Affluent Medical.

Read full article here.